radiosensitizer.
drug used to potentiate the effectiveness of radiation therapy in destroying unwanted cells
Nanobiotix Reports 79% Locoregional Control in Recurrent Lung Cancer Trial
Nanobiotix's updated Phase 1 data for JNJ-1900 (NBTXR3) in inoperable, locoregionally recurrent NSCLC show no dose-limiting toxicities and a feasible intratumoral injection, with one-year results of 79% locoregional control, 61% LPFS, and 70% OS achieved at a lower re-irradiation dose. The findings reinforce the hafnium oxide nanoparticle–based radiosensitizer's potential to enable safe retreatment and spur further enrollment in dose-escalation and expansion cohorts.
Health · 6 sources · Sep 14, 2026Read itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About radiosensitizer
A radiosensitizer is an agent that makes tumor cells more sensitive to radiation therapy. It is sometimes also known as a radiation sensitizer or radio-enhancer.
Everything about radiosensitizer →